Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-003078
Filing Date
2025-05-15
Accepted
2025-05-15 16:27:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5752
  Complete submission text file 0001950047-25-003078.txt   7221
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Subject) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38944 | Film No.: 25953917
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AKERO THERAPEUTICS INC. 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Yale Catriona (Reporting) CIK: 0001779308 (see all company filings)

Type: 144